+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
In-Vitro Diagnostics Quality Control Market - Global Forecast 2026-2032- Product Image
In-Vitro Diagnostics Quality Control Market - Global Forecast 2026-2032- Product Image
Sale

In-Vitro Diagnostics Quality Control Market - Global Forecast 2026-2032

  • Report

  • 194 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 4904896
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The In-Vitro Diagnostics Quality Control Market is projected to reach USD 1.74 Billion in 2026. It is expected to continue growing at a CAGR of 8.67%, reaching USD 2.88 Billion by 2032.

In-vitro diagnostics quality control is a mission-critical discipline that safeguards the accuracy, precision, reproducibility, and clinical reliability of laboratory testing. As hospitals, reference laboratories, public health networks, and point-of-care settings expand testing volumes, demand is rising for independent quality control materials, calibrators, proficiency testing, external quality assessment, laboratory information system integration, and standardized quality management practices.

The industry is shaped by internationally recognized requirements such as ISO 15189 for medical laboratories, CLIA requirements in the United States, accreditation practices, EU IVDR obligations, and regulator-led post-market surveillance. These frameworks reinforce the role of IVD quality control in reducing diagnostic error, supporting patient safety, maintaining traceability, and strengthening confidence in clinical decision-making across routine and specialized testing.

Transformative Shifts in the IVD Quality Control Landscape

The IVD quality control landscape is shifting from periodic, manual review toward continuous, risk-based, and digitally connected quality assurance. Laboratories are increasingly managing high-throughput immunoassay, clinical chemistry, hematology, microbiology, coagulation, urinalysis, and molecular diagnostics platforms, which require more sophisticated lot-to-lot verification, peer comparison, internal quality control, and instrument performance monitoring.

Regulatory modernization is also changing supplier and laboratory behavior. The EU IVDR has increased evidence requirements for IVD products, while FDA quality system expectations, global accreditation programs, and post-pandemic investments in diagnostic resilience have elevated demand for traceable, commutable, stable, and assay-relevant QC materials across centralized, near-patient, and decentralized testing environments.

Cumulative Impact of Artificial Intelligence on IVD Quality Control

Artificial intelligence is adding cumulative value across IVD quality control by improving anomaly detection, predictive maintenance, workflow triage, and statistical process monitoring. AI-enabled middleware can analyze Levey-Jennings trends, Westgard rule violations, peer group performance, reagent lot shifts, calibration bias, and instrument drift faster than manual review, helping laboratories intervene before quality failures affect patient results.

The strongest near-term impact is where AI supports, rather than replaces, validated quality management systems. Adoption depends on data integrity, explainability, cybersecurity, documented validation, auditability, and alignment with laboratory accreditation requirements. For QC material suppliers and diagnostic platform providers, AI creates opportunities to differentiate through connected controls, remote monitoring, automated exception management, and evidence-based decision support.

Key Regional Insights for IVD Quality Control

Asia-Pacific is expanding as China, India, Japan, South Korea, ASEAN countries, and Australia invest in healthcare infrastructure, infectious disease testing, oncology diagnostics, chronic disease management, and laboratory accreditation. China’s NMPA oversight, Japan’s PMDA pathway, India’s evolving CDSCO framework, South Korea’s MFDS regulation, and Australia’s NATA-accredited laboratory ecosystem are strengthening the need for reliable IVD quality control across routine and advanced diagnostics.

North America remains a mature, high-compliance region led by the United States and Canada, where CLIA, FDA quality system expectations, accreditation standards, and provincial laboratory requirements support sustained adoption of third-party controls, proficiency testing, and digital QC data management. Europe is being reshaped by IVDR implementation, ISO 15189-based laboratory competence, and stronger performance evidence expectations, while Latin America is led by Brazil and Mexico as laboratories modernize under ANVISA and COFEPRIS influence. The Middle East is advancing through GCC healthcare investment, national screening programs, and hospital accreditation, while Africa’s progress is tied to infectious disease programs, WHO-aligned laboratory quality systems, antimicrobial resistance surveillance, and expanded external quality assessment access.

Key Group Insights Across Global IVD Quality Control Markets

ASEAN markets are strengthening diagnostic quality through laboratory modernization, regional regulatory convergence, expanding universal health coverage initiatives, and growing access to molecular and point-of-care testing. The GCC is prioritizing high-quality hospital networks, national screening programs, medical tourism, and medical laboratory accreditation, creating demand for robust QC materials, proficiency testing, and digital quality systems.

The European Union is defined by IVDR implementation, notified body capacity, post-market performance follow-up, and evidence-based performance expectations, making quality control central to regulatory compliance and market access. BRICS countries combine scale with diverse regulatory maturity, creating opportunities for localized QC production, distributor education, and laboratory training. G7 markets lead in automation, accreditation, advanced diagnostics, and cybersecurity-aware data integration, while NATO countries increasingly view diagnostic readiness, supply security, and interoperable laboratory capacity as components of health system resilience.

Key Country Insights for IVD Quality Control

The United States leads through CLIA-regulated laboratories, FDA oversight, accreditation-driven quality systems, and strong use of third-party controls, proficiency testing, and peer comparison programs. Canada emphasizes provincial quality systems and accredited laboratory practice, while Mexico and Brazil are expanding diagnostic access under COFEPRIS and ANVISA oversight. In Europe, the United Kingdom, Germany, France, Italy, and Spain are advancing through ISO-aligned laboratory practices, national accreditation structures, and IVDR-influenced product requirements, while Russia maintains demand across hospital, regional, and public-sector diagnostic networks.

China is scaling domestic IVD manufacturing, hospital laboratory capacity, and NMPA-regulated diagnostic quality expectations; India is expanding diagnostics through public health programs and private laboratory networks; and Japan prioritizes precision, automation, quality assurance, and testing needs linked to an aging population. Australia maintains rigorous accreditation through NATA-linked systems and strong external quality assessment participation, while South Korea continues to grow through advanced diagnostics, export-oriented IVD manufacturing, digital health infrastructure, and technologically mature clinical laboratories.

Actionable Recommendations for IVD Quality Control Leaders

Industry leaders should prioritize commutable, matrix-appropriate, stable, and clinically relevant quality control materials that perform across multi-vendor testing platforms and diverse assay methodologies. Investment in lot-to-lot verification support, stability documentation, traceability, value assignment, uncertainty communication, and regulatory-ready technical files will improve competitiveness as laboratories demand higher confidence in QC performance.

Organizations should also build digital ecosystems around QC data, including peer comparison, middleware integration, automated rule monitoring, audit-ready reporting, and secure cloud-based analytics. Strategic partnerships with accredited laboratories, reference institutions, public health programs, and regional distributors can accelerate adoption, while training programs in ISO 15189, Westgard rules, risk-based quality management, and external quality assessment can strengthen customer retention and operational credibility.

Research Methodology for IVD Quality Control Analysis

This executive summary is based on a structured review of verified industry, regulatory, and clinical laboratory sources, including international laboratory standards, publicly available regulator guidance, accreditation frameworks, and established quality management practices in medical testing. The analysis considers product categories such as independent controls, calibrators, data management tools, proficiency testing, external quality assessment, and quality assurance services.

Regional and country insights were developed by evaluating regulatory maturity, healthcare infrastructure, diagnostic testing demand, laboratory accreditation adoption, public health investment, and adoption of automated and molecular diagnostic technologies. The methodology emphasizes data-backed interpretation, cross-source validation, and practical relevance for manufacturers, laboratories, distributors, healthcare providers, and investors operating in the IVD quality control ecosystem.

Conclusion: Quality Control as the Foundation of Reliable Diagnostics

In-vitro diagnostics quality control is becoming more strategic as laboratories face rising test complexity, stricter regulatory expectations, workforce constraints, and growing pressure to deliver accurate results at scale. The industry’s direction will be shaped by independent QC adoption, digital quality management, AI-supported monitoring, traceable materials, and broader use of proficiency testing and external quality assessment.

Organizations that combine scientifically robust QC materials with connected analytics, regulatory readiness, technical education, and regional expertise will be best positioned to grow responsibly. As diagnostic testing expands across centralized laboratories, decentralized care, public health networks, and point-of-care environments, quality control will remain essential to patient safety, clinical confidence, and sustainable IVD development.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. In-Vitro Diagnostics Quality Control Market, by Product Type
7.1. Introduction
7.2. Analyzers & Instruments
7.2.1. Automated Systems
7.2.2. Semi-Automated Systems
7.3. Control Materials
7.4. QC Reagents
7.4.1. Liquid Controls
7.4.2. Lyophilized Controls
7.5. Software Solutions
7.5.1. Data Management Systems
7.5.2. LIMS
7.5.3. QC Software
8. In-Vitro Diagnostics Quality Control Market, by Technology
8.1. Introduction
8.2. Clinical Chemistry
8.2.1. Colorimetric
8.2.2. Turbidimetric
8.3. Hematology
8.3.1. Automated Cell Counters
8.3.2. Flow Cytometry
8.4. Immunoassay
8.4.1. Chemiluminescence Immunoassay
8.4.2. ELISA
8.4.3. Fluorescence Immunoassay
8.5. Microbiology
8.5.1. Culture
8.5.2. PCR
8.6. Molecular Diagnostics
8.6.1. Next-Generation Sequencing
8.6.2. PCR
9. In-Vitro Diagnostics Quality Control Market, by Application
9.1. Introduction
9.2. Cardiology
9.2.1. Cardiac Marker Testing
9.2.2. Point-Of-Care Testing
9.3. Genetic Testing
9.3.1. Carrier Screening
9.3.2. Prenatal Testing
9.4. Infectious Disease Testing
9.4.1. Bacterial Detection
9.4.2. Viral Detection
9.5. Oncology
9.5.1. Minimal Residual Disease
9.5.2. Tumor Marker Testing
9.6. Toxicology
9.6.1. Drugs Of Abuse
9.6.2. Therapeutic Drug Monitoring
10. In-Vitro Diagnostics Quality Control Market, by End User
10.1. Introduction
10.2. Blood Banks
10.2.1. National Blood Banks
10.2.2. Regional Blood Banks
10.3. Diagnostic Laboratories
10.3.1. Hospital-Based Laboratories
10.3.2. Independent Laboratories
10.4. Hospitals & Clinics
10.4.1. Clinic Laboratories
10.4.2. Reference Laboratories
10.5. Research Institutes
10.5.1. Academic Institutes
10.5.2. Private Research Laboratories
11. In-Vitro Diagnostics Quality Control Market, by Region
11.1. Asia-Pacific
11.2. North America
11.3. Latin America
11.4. Europe
11.5. Middle East
11.6. Africa
12. In-Vitro Diagnostics Quality Control Market, by Group
12.1. ASEAN
12.2. GCC
12.3. European Union
12.4. BRICS
12.5. G7
12.6. NATO
13. In-Vitro Diagnostics Quality Control Market, by Country
13.1. United States
13.2. Canada
13.3. Mexico
13.4. Brazil
13.5. United Kingdom
13.6. Germany
13.7. France
13.8. Russia
13.9. Italy
13.10. Spain
13.11. China
13.12. India
13.13. Japan
13.14. Australia
13.15. South Korea
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. AccuBioTech Co., Ltd.
15.3. Becton, Dickinson and Company
15.4. Bio-Rad Laboratories, Inc.
15.5. Bio-Techne Corporation
15.6. bioMérieux SA
15.7. BioSystems S.A.
15.8. Danaher Corporation
15.9. DiaSorin S.p.A.
15.10. EKF Diagnostics Holdings plc
15.11. F. Hoffmann-La Roche Ltd.
15.12. Fujirebio Holdings, Inc.
15.13. Helena Laboratories
15.14. Instand e.V.
15.15. LGC Limited
15.16. Maine Molecular Quality Controls, Inc.
15.17. Meridian Bioscience, Inc.
15.18. Microbiologics Inc.
15.19. Microbix Biosystems Inc.
15.20. Qnostics Ltd.
15.21. QuidelOrtho Corporation
15.22. Randox Laboratories Ltd.
15.23. Randox Toxicology
15.24. SEKISUI Diagnostics, LLC
15.25. SeraCare Life Sciences
15.26. Siemens Healthineers AG
15.27. Sun Diagnostics, LLC
15.28. Sysmex Corporation
15.29. Technopath Clinical Diagnostics
15.30. Thermo Fisher Scientific Inc.
List of Figures
FIGURE 1. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2025 VS 2032 (%)
FIGURE 11. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 13. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL ANALYZERS & INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL ANALYZERS & INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL ANALYZERS & INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL SEMI-AUTOMATED SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL SEMI-AUTOMATED SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL SEMI-AUTOMATED SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL CONTROL MATERIALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL CONTROL MATERIALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL CONTROL MATERIALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL QC REAGENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL QC REAGENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL QC REAGENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL LIQUID CONTROLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL LIQUID CONTROLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL LIQUID CONTROLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL LYOPHILIZED CONTROLS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL LYOPHILIZED CONTROLS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL LYOPHILIZED CONTROLS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL SOFTWARE SOLUTIONS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL SOFTWARE SOLUTIONS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL SOFTWARE SOLUTIONS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL DATA MANAGEMENT SYSTEMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL LIMS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL LIMS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL LIMS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL QC SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL QC SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL QC SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL CLINICAL CHEMISTRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL COLORIMETRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL COLORIMETRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL COLORIMETRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL TURBIDIMETRIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL TURBIDIMETRIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL TURBIDIMETRIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL HEMATOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL HEMATOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL HEMATOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL AUTOMATED CELL COUNTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL AUTOMATED CELL COUNTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL AUTOMATED CELL COUNTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL CHEMILUMINESCENCE IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL ELISA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL ELISA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL FLUORESCENCE IMMUNOASSAY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL FLUORESCENCE IMMUNOASSAY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL FLUORESCENCE IMMUNOASSAY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL MICROBIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL MICROBIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL MICROBIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL CULTURE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CULTURE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CULTURE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL MOLECULAR DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL NEXT-GENERATION SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL CARDIOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL CARDIOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL CARDIOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL CARDIAC MARKER TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL POINT-OF-CARE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL GENETIC TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL GENETIC TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL GENETIC TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL CARRIER SCREENING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL CARRIER SCREENING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL CARRIER SCREENING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL PRENATAL TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL PRENATAL TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL PRENATAL TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL INFECTIOUS DISEASE TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL BACTERIAL DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL BACTERIAL DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 110. GLOBAL BACTERIAL DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 111. GLOBAL VIRAL DETECTION MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 112. GLOBAL VIRAL DETECTION MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 113. GLOBAL VIRAL DETECTION MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 114. GLOBAL ONCOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 115. GLOBAL ONCOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 116. GLOBAL ONCOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 117. GLOBAL MINIMAL RESIDUAL DISEASE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 118. GLOBAL MINIMAL RESIDUAL DISEASE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 119. GLOBAL MINIMAL RESIDUAL DISEASE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 120. GLOBAL TUMOR MARKER TESTING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 121. GLOBAL TUMOR MARKER TESTING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 122. GLOBAL TUMOR MARKER TESTING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 123. GLOBAL TOXICOLOGY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 124. GLOBAL TOXICOLOGY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 125. GLOBAL TOXICOLOGY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 126. GLOBAL DRUGS OF ABUSE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. GLOBAL DRUGS OF ABUSE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 128. GLOBAL DRUGS OF ABUSE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 129. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 130. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 131. GLOBAL THERAPEUTIC DRUG MONITORING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 132. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 133. GLOBAL BLOOD BANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 134. GLOBAL BLOOD BANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 135. GLOBAL BLOOD BANKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 136. GLOBAL NATIONAL BLOOD BANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 137. GLOBAL NATIONAL BLOOD BANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 138. GLOBAL NATIONAL BLOOD BANKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 139. GLOBAL REGIONAL BLOOD BANKS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 140. GLOBAL REGIONAL BLOOD BANKS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 141. GLOBAL REGIONAL BLOOD BANKS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 142. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 144. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 145. GLOBAL HOSPITAL-BASED LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 146. GLOBAL HOSPITAL-BASED LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 147. GLOBAL HOSPITAL-BASED LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 148. GLOBAL INDEPENDENT LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 149. GLOBAL INDEPENDENT LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 150. GLOBAL INDEPENDENT LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 151. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 152. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 153. GLOBAL HOSPITALS & CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 154. GLOBAL CLINIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 155. GLOBAL CLINIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 156. GLOBAL CLINIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 157. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 158. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 159. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 160. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 161. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 162. GLOBAL RESEARCH INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 163. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 164. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 165. GLOBAL ACADEMIC INSTITUTES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 166. GLOBAL PRIVATE RESEARCH LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 167. GLOBAL PRIVATE RESEARCH LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 168. GLOBAL PRIVATE RESEARCH LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 169. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 170. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 171. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 172. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 173. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2017-2032 (USD MILLION)
TABLE 174. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 175. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 176. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 177. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2017-2032 (USD MILLION)
TABLE 178. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 179. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2017-2032 (USD MILLION)
TABLE 180. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 181. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 182. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 183. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2017-2032 (USD MILLION)
TABLE 184. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2017-2032 (USD MILLION)
TABLE 185. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 186. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 187. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 188. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2017-2032 (USD MILLION)
TABLE 189. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 190. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 191. ASIA-PACIFIC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 192. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 193. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 194. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 195. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2017-2032 (USD MILLION)
TABLE 196. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 197. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 198. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 199. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2017-2032 (USD MILLION)
TABLE 200. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 201. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2017-2032 (USD MILLION)
TABLE 202. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 203. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 204. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 205. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2017-2032 (USD MILLION)
TABLE 206. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2017-2032 (USD MILLION)
TABLE 207. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 208. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 209. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 210. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2017-2032 (USD MILLION)
TABLE 211. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 212. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 213. NORTH AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 214. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 215. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 216. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 217. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2017-2032 (USD MILLION)
TABLE 218. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 219. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 220. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 221. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2017-2032 (USD MILLION)
TABLE 222. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 223. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2017-2032 (USD MILLION)
TABLE 224. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 225. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 226. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 227. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2017-2032 (USD MILLION)
TABLE 228. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2017-2032 (USD MILLION)
TABLE 229. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 230. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 231. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 232. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2017-2032 (USD MILLION)
TABLE 233. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 234. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 235. LATIN AMERICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 236. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 237. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 238. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 239. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2017-2032 (USD MILLION)
TABLE 240. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 241. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 242. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 243. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2017-2032 (USD MILLION)
TABLE 244. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 245. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2017-2032 (USD MILLION)
TABLE 246. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 247. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 248. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 249. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2017-2032 (USD MILLION)
TABLE 250. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2017-2032 (USD MILLION)
TABLE 251. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 252. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 253. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 254. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2017-2032 (USD MILLION)
TABLE 255. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 256. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 257. EUROPE IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 258. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 259. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 260. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 261. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2017-2032 (USD MILLION)
TABLE 262. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 263. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 264. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 265. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2017-2032 (USD MILLION)
TABLE 266. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 267. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2017-2032 (USD MILLION)
TABLE 268. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 269. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 270. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 271. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2017-2032 (USD MILLION)
TABLE 272. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2017-2032 (USD MILLION)
TABLE 273. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 274. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 275. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 276. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2017-2032 (USD MILLION)
TABLE 277. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 278. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 279. MIDDLE EAST IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 280. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 281. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 282. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 283. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2017-2032 (USD MILLION)
TABLE 284. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 285. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 286. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 287. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2017-2032 (USD MILLION)
TABLE 288. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 289. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2017-2032 (USD MILLION)
TABLE 290. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 291. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 292. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 293. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2017-2032 (USD MILLION)
TABLE 294. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2017-2032 (USD MILLION)
TABLE 295. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 296. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 297. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2017-2032 (USD MILLION)
TABLE 299. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 300. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 301. AFRICA IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 302. GLOBAL IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 303. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 304. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 305. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 306. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2017-2032 (USD MILLION)
TABLE 307. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 308. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 309. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 310. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HEMATOLOGY, 2017-2032 (USD MILLION)
TABLE 311. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY IMMUNOASSAY, 2017-2032 (USD MILLION)
TABLE 312. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MICROBIOLOGY, 2017-2032 (USD MILLION)
TABLE 313. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY MOLECULAR DIAGNOSTICS, 2017-2032 (USD MILLION)
TABLE 314. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY APPLICATION, 2017-2032 (USD MILLION)
TABLE 315. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CARDIOLOGY, 2017-2032 (USD MILLION)
TABLE 316. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GENETIC TESTING, 2017-2032 (USD MILLION)
TABLE 317. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY INFECTIOUS DISEASE TESTING, 2017-2032 (USD MILLION)
TABLE 318. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ONCOLOGY, 2017-2032 (USD MILLION)
TABLE 319. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TOXICOLOGY, 2017-2032 (USD MILLION)
TABLE 320. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 321. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY BLOOD BANKS, 2017-2032 (USD MILLION)
TABLE 322. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 323. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY HOSPITALS & CLINICS, 2017-2032 (USD MILLION)
TABLE 324. ASEAN IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY RESEARCH INSTITUTES, 2017-2032 (USD MILLION)
TABLE 325. GCC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 326. GCC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 327. GCC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY ANALYZERS & INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 328. GCC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY QC REAGENTS, 2017-2032 (USD MILLION)
TABLE 329. GCC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY SOFTWARE SOLUTIONS, 2017-2032 (USD MILLION)
TABLE 330. GCC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 331. GCC IN-VITRO DIAGNOSTICS QUALITY CONTROL MARKET SIZE, BY CLINICAL CHEMISTRY, 2017-2032 (USD MILLION)
TABLE 332. GCC IN-V

Companies Mentioned

  • Abbott Laboratories
  • AccuBioTech Co., Ltd.
  • Becton, Dickinson and Company
  • Bio-Rad Laboratories, Inc.
  • Bio-Techne Corporation
  • bioMérieux SA
  • BioSystems S.A.
  • Danaher Corporation
  • DiaSorin S.p.A.
  • EKF Diagnostics Holdings plc
  • F. Hoffmann-La Roche Ltd.
  • Fujirebio Holdings, Inc.
  • Helena Laboratories
  • Instand e.V.
  • LGC Limited
  • Maine Molecular Quality Controls, Inc.
  • Meridian Bioscience, Inc.
  • Microbiologics Inc.
  • Microbix Biosystems Inc.
  • Qnostics Ltd.
  • QuidelOrtho Corporation
  • Randox Laboratories Ltd.
  • Randox Toxicology
  • SEKISUI Diagnostics, LLC
  • SeraCare Life Sciences
  • Siemens Healthineers AG
  • Sun Diagnostics, LLC
  • Sysmex Corporation
  • Technopath Clinical Diagnostics
  • Thermo Fisher Scientific Inc.

Table Information

Report AttributeDetails
No. of Pages194
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.74 Billion
Forecasted Market Value ( USD ) by 2032 $ 2.88 Billion
Compound Annual Growth Rate8.6%
Regions CoveredGlobal
No. of Companies Mentioned30

Related Topics

Related Reports

In-Vitro Diagnostics Quality Control - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031) - Product Image

In-Vitro Diagnostics Quality Control - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2026-2031)

  • Report
  • 110 Pages
  • Global
From
In-Vitro Diagnostics Quality Control Market Outlook 2026-2034: Market Share, and Growth Analysis by Products & Services (Quality Control Products, Data Management Solutions, Quality Assurance Services), Application, End User - Product Image

In-Vitro Diagnostics Quality Control Market Outlook 2026-2034: Market Share, and Growth Analysis by Products & Services (Quality Control Products, Data Management Solutions, Quality Assurance Services), Application, End User

  • Report
  • 160 Pages
  • Global
From
In Vitro Diagnostics Quality Control Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F - Product Image

In Vitro Diagnostics Quality Control Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2021-2031F

  • Report
  • 180 Pages
  • Global
From
In Vitro Diagnostics Quality Control Market by Product & Service, Technology, Manufacturer, End User, and Region - Global Forecast to 2030 - Product Image

In Vitro Diagnostics Quality Control Market by Product & Service, Technology, Manufacturer, End User, and Region - Global Forecast to 2030

  • Report
  • 379 Pages
  • Global
From
In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides - Product Image

In Vitro Diagnostic Quality Control Market: Strategy & Trends with Forecasts by Assay Type, by Place, by Product, by Manufacturer and by Country - Situation Analysis with Executive & Consultant Guides

  • Report
  • 372 Pages
  • Global
From
Copyright © 2002-2026 Research and Markets. All Rights Reserved.